Alabama
Alabaster; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Anniston; Research Site
The purpose of this research program is to assess the effectiveness and safety of a study drug in patients with PGTC Seizures.
Birmingham; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Birmingham; Research Center
A clinical trial for adult patients with epilepsy consisting of uncontrolled partial-onset seizures.
Birmingham; Research Site
The purpose of this research program is to assess the effectiveness and safety of a study drug in patients with PGTC Seizures.
Birmingham; University of Alabama
RNS™ System Pivotal Clinical Investigation
Huntsville; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Northport; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Alaska
Little Rock; Research Site
The purpose of this research program is to assess the effectiveness and safety of a study drug in patients with PGTC Seizures.
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Arizona
Phoenix; Research Center
A Study to Evaluate the Effects of Two Marketed Drugs in Patients with Epilepsy.
Phoenix; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Phoenix; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Phoenix; Lovelace Scientific Resources - AZ
Do you or some you know have epilepsy?
Phoenix; Research Center
A clinical trial for adult patients with epilepsy consisting of uncontrolled partial-onset seizures.
Phoenix; Research Center
A Study to Evaluate the Effects of Two Marketed Drugs in Patients with Epilepsy.
Tucson; Research Center
A Study to Evaluate the Effects of Two Marketed Drugs in Patients with Epilepsy.
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Arkansas
Little Rock; Clinical Trials, Inc
Epilepsy and non-controlled partial seizures
Little Rock; Clinical Trials, Inc.
Refractory Epilepsy and acute repetitive seizures (ARS)
Little Rock; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Little Rock; Clinical Trials, Inc.
Epilepsy and non-controlled partial seizures
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
California
Costa Mesa; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
La Jolla; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy
Los Angeles; Research Center
A clinical trial for adult patients with epilepsy consisting of uncontrolled partial-onset seizures.
Los Angeles; University of Southern California
RNS™ System Pivotal Clinical Investigation
Newport Beach; Research Site
The purpose of this research program is to assess the effectiveness and safety of a study drug in patients with PGTC Seizures.
Newport Beach; Research Center
A Study to Evaluate the Effects of Two Marketed Drugs in Patients with Epilepsy.
North Hills; Research Site
The purpose of this research program is to assess the effectiveness and safety of a study drug in patients with PGTC Seizures.
Oxnard; Research Center
A Study to Evaluate the Effects of Two Marketed Drugs in Patients with Epilepsy.
Sacramento; Sutter Institute for Medical Research (SIMR)
Epilepsy: Acute Repetitive Seizures
Sacramento; Sutter Institute for Medical Research (SIMR)
Epilepsy: Refractory Partial Seizures
Sacramento; Research Center
A clinical trial for adult patients with epilepsy consisting of uncontrolled partial-onset seizures.
San Diego; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy
San Francisco; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
San Francisco; California Pacific Medical Center
RNS™ System Pivotal Clinical Investigation
Santa Monica; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Santa Monica; Research Site
The purpose of this research program is to assess the effectiveness and safety of a study drug in patients with PGTC Seizures.
Sylmar; UCLA Medical Center
Trigeminal Nerve Stimulation for Epilepsy
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
West Los Angeles; Research Site
The purpose of this research program is to assess the effectiveness and safety of a study drug in patients with PGTC Seizures.
Colorado
Denver; Research Center
A Study to Evaluate the Effects of Two Marketed Drugs in Patients with Epilepsy.
Lakewood; Research Center
A Study to Evaluate the Effects of Two Marketed Drugs in Patients with Epilepsy.
Longmont; Research Center
A Study to Evaluate the Effects of Two Marketed Drugs in Patients with Epilepsy.
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Connecticut
Fairfield; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
New Haven; Research Center
A clinical trial for adult patients with epilepsy consisting of uncontrolled partial-onset seizures.
New Haven; Yale University School of Medicine
RNS™ System Pivotal Clinical Investigation
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Delaware
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Florida
Boca Raton; Research Center
A Study to Evaluate the Effects of Two Marketed Drugs in Patients with Epilepsy.
Gainesville; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Gainesville; Research Center
A clinical trial for adult patients with epilepsy consisting of uncontrolled partial-onset seizures.
Gainesville; University of Florida
RNS™ System Pivotal Clinical Investigation
Jacksonville; Research Center
A Study to Evaluate the Effects of Two Marketed Drugs in Patients with Epilepsy.
Maitland; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Orlando; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Panama City; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Panama City; Research Center
A Study to Evaluate the Effects of Two Marketed Drugs in Patients with Epilepsy.
Petersburg; Research Center
A Study to Evaluate the Effects of Two Marketed Drugs in Patients with Epilepsy.
Sarasota; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Sarasota; Lovelace Scientific Resources - Sarasota
Epilepsy
Tallahasse; Research Center
A Study to Evaluate the Effects of Two Marketed Drugs in Patients with Epilepsy.
Tallahassee; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Tampa; Research Center
A Study to Evaluate the Effects of Two Marketed Drugs in Patients with Epilepsy.
Tampa; Research Center
A Study to Evaluate the Effects of Two Marketed Drugs in Patients with Epilepsy.
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Georgia
Atlanta; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Atlanta; Neurotrials Research, Inc.
Do you suffer from Seizures?
Atlanta; Research Center
A clinical trial for adult patients with epilepsy consisting of uncontrolled partial-onset seizures.
Atlanta; Research Site
The purpose of this research program is to assess the effectiveness and safety of a study drug in patients with PGTC Seizures.
Atlanta; Research Center
A Study to Evaluate the Effects of Two Marketed Drugs in Patients with Epilepsy.
Augusta; Research Center
A clinical trial for adult patients with epilepsy consisting of uncontrolled partial-onset seizures.
Augusta; Research Center
A Study to Evaluate the Effects of Two Marketed Drugs in Patients with Epilepsy.
Augusta; Medical College of Georgia
RNS™ System Pivotal Clinical Investigation
Canton; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Conyers; Research Center
A Study to Evaluate the Effects of Two Marketed Drugs in Patients with Epilepsy.
Decatur; Research Center
A Study to Evaluate the Effects of Two Marketed Drugs in Patients with Epilepsy.
Marietta; Research Center
A Study to Evaluate the Effects of Two Marketed Drugs in Patients with Epilepsy.
Savannah; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Savannah; Research Site
The purpose of this research program is to assess the effectiveness and safety of a study drug in patients with PGTC Seizures.
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Hawaii
Honolulu; Research Center
A Study to Evaluate the Effects of Two Marketed Drugs in Patients with Epilepsy.
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Idaho
Boise; Research Center
A Study to Evaluate the Effects of Two Marketed Drugs in Patients with Epilepsy.
Boise; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Illinois
Chicago; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Chicago; Research Site
The purpose of this research program is to assess the effectiveness and safety of a study drug in patients with PGTC Seizures.
Flossmoor; Research Site
The purpose of this research program is to assess the effectiveness and safety of a study drug in patients with PGTC Seizures.
Springfield; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Springfield; Research Center
A clinical trial for adult patients with epilepsy consisting of uncontrolled partial-onset seizures.
Springfield; Research Site
The purpose of this research program is to assess the effectiveness and safety of a study drug in patients with PGTC Seizures.
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Indiana
Indianapolis; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Indianapolis; Research Center
A Study to Evaluate the Effects of Two Marketed Drugs in Patients with Epilepsy.
Indianapolis; Indiana University
RNS™ System Pivotal Clinical Investigation
Lafayette; Research Center
A Study to Evaluate the Effects of Two Marketed Drugs in Patients with Epilepsy.
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Iowa
Ames; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Des Moines; Research Center
A Study to Evaluate the Effects of Two Marketed Drugs in Patients with Epilepsy.
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Kansas
Kansas City; Research Center
A Study to Evaluate the Effects of Two Marketed Drugs in Patients with Epilepsy.
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Wichita; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Wichita; Research Site
The purpose of this research program is to assess the effectiveness and safety of a study drug in patients with PGTC Seizures.
Wichita; Research Center
A Study to Evaluate the Effects of Two Marketed Drugs in Patients with Epilepsy.
Wichita; Via Christi Comprehensive Epilepsy Center
RNS™ System Pivotal Clinical Investigation
Kentucky
Crestview Hills; Research Site
The purpose of this research program is to assess the effectiveness and safety of a study drug in patients with PGTC Seizures.
Lexington; Research Center
A Study to Evaluate the Effects of Two Marketed Drugs in Patients with Epilepsy.
Lexington; Research Center
A Study to Evaluate the Effects of Two Marketed Drugs in Patients with Epilepsy.
Louisville; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Louisville; Research Site
The purpose of this research program is to assess the effectiveness and safety of a study drug in patients with PGTC Seizures.
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Louisiana
New Orleans; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Maine
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Maryland
Baltimore; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Baltimore; UCB Clinical Trial Call Center
Trial to Assess the Long-Term Safety of Oral Lacosamide in Patients With Partial-Onset Seizures
Baltimore; UCB Clinical Trial Call Center
Trial to Assess the Safety of a Single Dose of iv Lacosamide Followed by Twice Daily Oral Lacosamide in Patients With Partial-Onset Seizures.
Baltimore; Johns Hopkins University
RNS™ System Pivotal Clinical Investigation
Bethesda; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Pikesville; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Massachusetts
Bellingham; CNS Research of MA, Inc.
A Study of the Safety and Preliminary Effectiveness of the Investigative Compound RWJ-333369 in Patients With Epilepsy.
Boston; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy
Boston; Research Site
The purpose of this research program is to assess the effectiveness and safety of a study drug in patients with PGTC Seizures.
Boston; Massachusetts General Hospital
RNS™ System Pivotal Clinical Investigation
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Michigan
Detroit; Research Site
The purpose of this research program is to assess the effectiveness and safety of a study drug in patients with PGTC Seizures.
Detroit; Henry Ford Hospital
RNS™ System Pivotal Clinical Investigation
Grand Rapids; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Traverse City; Research Site
The purpose of this research program is to assess the effectiveness and safety of a study drug in patients with PGTC Seizures.
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Minnesota
Golden Valley; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Golden Valley; Research Site
The purpose of this research program is to assess the effectiveness and safety of a study drug in patients with PGTC Seizures.
Minneapolis; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Minneapolis; Research Site
The purpose of this research program is to assess the effectiveness and safety of a study drug in patients with PGTC Seizures.
Minneapolis; Research Center
A Study to Evaluate the Effects of Two Marketed Drugs in Patients with Epilepsy.
St. Paul; Research Center
A clinical trial for adult patients with epilepsy consisting of uncontrolled partial-onset seizures.
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Mississippi
Hattiesburg; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Missouri
Chesterfield; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Chesterfield; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy
Chesterfield; UCB Clinical Trial Call Center
Trial to Assess the Safety of a Single Dose of iv Lacosamide Followed by Twice Daily Oral Lacosamide in Patients With Partial-Onset Seizures.
Chesterfield; UCB Clinical Trial Call Center
Trial to Assess the Long-Term Safety of Oral Lacosamide in Patients With Partial-Onset Seizures
Chesterfield; Research Site
The purpose of this research program is to assess the effectiveness and safety of a study drug in patients with PGTC Seizures.
St Louis; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Montana
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Nebraska
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Nevada
Henderson; Lovelace Scientific Resources, Inc.
Lamotrigine Extended-Release in Elderly Patients with Epilepsy
Las Vegas; Research Site
The purpose of this research program is to assess the effectiveness and safety of a study drug in patients with PGTC Seizures.
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
New Hampshire
Lebanon; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Lebanon; Dartmouth-Hitchcock Medical Center
RNS™ System Pivotal Clinical Investigation
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
New Jersey
Edison; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Edison; Research Site
The purpose of this research program is to assess the effectiveness and safety of a study drug in patients with PGTC Seizures.
Newark; Research Center
A Study to Evaluate the Effects of Two Marketed Drugs in Patients with Epilepsy.
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Voorhees; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
New Mexico
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
New York
Albany; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Albany; Research Center
A clinical trial for adult patients with epilepsy consisting of uncontrolled partial-onset seizures.
Amherst; Research Center
A Study to Evaluate the Effects of Two Marketed Drugs in Patients with Epilepsy.
Bronx; Biomedical Research Alliance of New York
Refractory Partial Seizures-Adults and Minors
Bronx; Biomedical Research Alliance of New York
Photosensitivity Study - Adults
Buffalo; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy
Cedarhurst; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
New Hyde Park; Biomedical Research Alliance of New York
Fine motor coordination in patients with epilepsy treated with antiepileptic drugs
New Hyde Park; Research Center
A Study to Evaluate the Effects of Two Marketed Drugs in Patients with Epilepsy.
New York; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
New York; Biomedical Research Alliance of New York
Epilepsy consisting of uncontrolled partial-onset seizures - Adults
New York; Biomedical Research Alliance of New York![[*]](../images/newtiny.gif)
Refractory Partial Seizures
New York; Columbia University Medical Center
Multicenter Genetic Study of Rolandic Epilepsy
New York; Biomedical Research Alliance of New York
Refractory Partial Seizures
New York; Biomedical Research Alliance of New York
Epilepsy
Rochester; Research Center
A Study to Evaluate the Effects of Two Marketed Drugs in Patients with Epilepsy.
Rochester; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Rochester; University of Rochester
RNS™ System Pivotal Clinical Investigation
Syracuse; Research Center
A clinical trial for adult patients with epilepsy consisting of uncontrolled partial-onset seizures.
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
North Carolina
Asheville; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Asheville; Research Site
The purpose of this research program is to assess the effectiveness and safety of a study drug in patients with PGTC Seizures.
Chapel Hill; Research Center
A Study to Evaluate the Effects of Two Marketed Drugs in Patients with Epilepsy.
Durham; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Winston Salem; Research Center
A Study to Evaluate the Effects of Two Marketed Drugs in Patients with Epilepsy.
Winston-Salem; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
North Dakota
Bismarck; Odyssey Research Services
An Epilepsy Research Study
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Ohio
Cleveland; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Cleveland; UCB Clinical Trial Call Center
Trial to Assess the Long-Term Safety of Oral Lacosamide in Patients With Partial-Onset Seizures
Cleveland; UCB Clinical Trial Call Center
Trial to Assess the Safety of a Single Dose of iv Lacosamide Followed by Twice Daily Oral Lacosamide in Patients With Partial-Onset Seizures.
Columbus; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Columbus; UCB Clinical Trial Call Center
Trial to Assess the Safety of a Single Dose of iv Lacosamide Followed by Twice Daily Oral Lacosamide in Patients With Partial-Onset Seizures.
Columbus; UCB Clinical Trial Call Center
Trial to Assess the Long-Term Safety of Oral Lacosamide in Patients With Partial-Onset Seizures
Columbus; Research Center
A clinical trial for adult patients with epilepsy consisting of uncontrolled partial-onset seizures.
Columbus; Research Center
A Study to Evaluate the Effects of Two Marketed Drugs in Patients with Epilepsy.
Columbus; Research Center
A Study to Evaluate the Effects of Two Marketed Drugs in Patients with Epilepsy.
Columbus; Research Site
The purpose of this research program is to assess the effectiveness and safety of a study drug in patients with PGTC Seizures.
Toledo; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Oklahoma
Oklahoma City; Research Center
A Study to Evaluate the Effects of Two Marketed Drugs in Patients with Epilepsy.
Oklahoma City; Research Site
The purpose of this research program is to assess the effectiveness and safety of a study drug in patients with PGTC Seizures.
Tulsa; Research Center
A Study to Evaluate the Effects of Two Marketed Drugs in Patients with Epilepsy.
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Oregon
Medford; Research Center
A Study to Evaluate the Effects of Two Marketed Drugs in Patients with Epilepsy.
Medford; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Portland; Oregon Health & Sciences University
RNS™ System Pivotal Clinical Investigation
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Pennsylvania
Media; Research Center
A clinical trial for adult patients with epilepsy consisting of uncontrolled partial-onset seizures.
Philadelphia; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy
Philadelphia; Research Center
A clinical trial for adult patients with epilepsy consisting of uncontrolled partial-onset seizures.
Philadelphia; Research Site
The purpose of this research program is to assess the effectiveness and safety of a study drug in patients with PGTC Seizures.
Philadelphia; Research Site
The purpose of this research program is to assess the effectiveness and safety of a study drug in patients with PGTC Seizures.
Tarentum; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Rhode Island
East Providence; Research Center
A Study to Evaluate the Effects of Two Marketed Drugs in Patients with Epilepsy.
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Woonsocket; Research Center
A Study to Evaluate the Effects of Two Marketed Drugs in Patients with Epilepsy.
South Carolina
Beaufort; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
South Dakota
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Tennessee
Bristol; Research Center
A Study to Evaluate the Effects of Two Marketed Drugs in Patients with Epilepsy.
Germantown; Research Site
The purpose of this research program is to assess the effectiveness and safety of a study drug in patients with PGTC Seizures.
Memphis; Research Center
A Study to Evaluate the Effects of Two Marketed Drugs in Patients with Epilepsy.
Nashville; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Nashville; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy
Nashville; UCB Clinical Trial Call Center
Trial to Assess the Safety of a Single Dose of iv Lacosamide Followed by Twice Daily Oral Lacosamide in Patients With Partial-Onset Seizures.
Nashville; UCB Clinical Trial Call Center
Trial to Assess the Long-Term Safety of Oral Lacosamide in Patients With Partial-Onset Seizures
Nashville; Access Clinical Trials, Inc. - Nashville
Epilepsy and Partial-onset Seizures. Do You Or Someone You Know Have Epilepsy?
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Texas
Dallas; Research Center
A Study to Evaluate the Effects of Two Marketed Drugs in Patients with Epilepsy.
Dallas; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Dallas; UCB Clinical Trial Call Center
Trial to Assess the Safety of a Single Dose of iv Lacosamide Followed by Twice Daily Oral Lacosamide in Patients With Partial-Onset Seizures.
Dallas; UCB Clinical Trial Call Center
Trial to Assess the Long-Term Safety of Oral Lacosamide in Patients With Partial-Onset Seizures
Dallas; Research Site
The purpose of this research program is to assess the effectiveness and safety of a study drug in patients with PGTC Seizures.
Dallas; Research Center
A Study to Evaluate the Effects of Two Marketed Drugs in Patients with Epilepsy.
El Paso; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Fort Worth; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy
Houston; Research Center
A Study to Evaluate the Effects of Two Marketed Drugs in Patients with Epilepsy.
Houston; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Houston; Research Site
The purpose of this research program is to assess the effectiveness and safety of a study drug in patients with PGTC Seizures.
Houston; Research Center
A Study to Evaluate the Effects of Two Marketed Drugs in Patients with Epilepsy.
Houston; Baylor College of Medicine
RNS™ System Pivotal Clinical Investigation
Killeen; Research Center
A Study to Evaluate the Effects of Two Marketed Drugs in Patients with Epilepsy.
San Antonio; Research Center
A Study to Evaluate the Effects of Two Marketed Drugs in Patients with Epilepsy.
San Antonio; Research Center
A Study to Evaluate the Effects of Two Marketed Drugs in Patients with Epilepsy.
San Antonio; Research Site
The purpose of this research program is to assess the effectiveness and safety of a study drug in patients with PGTC Seizures.
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Utah
Salt Lake City; Research Center
A Study to Evaluate the Effects of Two Marketed Drugs in Patients with Epilepsy.
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Vermont
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Virginia
Charlottesville; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Charlottesville; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Charlottesville; UCB Clinical Trial Call Center
Trial to Assess the Long-Term Safety of Oral Lacosamide in Patients With Partial-Onset Seizures
Charlottesville; UCB Clinical Trial Call Center
Trial to Assess the Safety of a Single Dose of iv Lacosamide Followed by Twice Daily Oral Lacosamide in Patients With Partial-Onset Seizures.
Richmond; Research Center
A Study to Evaluate the Effects of Two Marketed Drugs in Patients with Epilepsy.
Richmond; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy
Richmond; Research Center
A clinical trial for adult patients with epilepsy consisting of uncontrolled partial-onset seizures.
Richmond; Research Site
The purpose of this research program is to assess the effectiveness and safety of a study drug in patients with PGTC Seizures.
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Washington
Seattle; Research Center
A Study to Evaluate the Effects of Two Marketed Drugs in Patients with Epilepsy.
Seattle; Swedish Medical Center
RNS™ System Pivotal Clinical Investigation
Tacoma; Research Center
A Study to Evaluate the Effects of Two Marketed Drugs in Patients with Epilepsy.
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Washington, DC
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Washington; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Washington; Research Center
A clinical trial for adult patients with epilepsy consisting of uncontrolled partial-onset seizures.
Washington; Research Site
The purpose of this research program is to assess the effectiveness and safety of a study drug in patients with PGTC Seizures.
Washington; George Washington University
RNS™ System Pivotal Clinical Investigation
West Virginia
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Wisconsin
Madison; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Madison; Research Site
The purpose of this research program is to assess the effectiveness and safety of a study drug in patients with PGTC Seizures.
Madison; University of Wisconsin School of Medicine and Public Health
RNS™ System Pivotal Clinical Investigation
Milwaukee; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Milwaukee; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Wausau; Research Center
A Study to Evaluate the Effects of Two Marketed Drugs in Patients with Epilepsy.
Wyoming
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
International
Graz, Austria; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
Innsbrick, Austria; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
Linz, Austria; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
Wien, Austria; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
Antwerpen, Belgium; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Brugge, Belgium; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
Brussels, Belgium; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy
EDEGEM, Belgium; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Gent, Belgium; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Gent, Belgium; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy
Godinne, Belgium; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
LEUVEN, Belgium; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Leuven, Belgium; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
Leuven, Belgium; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy
Liege, Belgium; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Liege, Belgium; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy
Montignies Sur Sambre, Belgium; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
Saint-Vith, Belgium; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Montreal, Quebec, Canada; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Quebec, QC, Canada; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Vancouver, BC, Canada; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Beroun, Czech Republic; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
BEROUN, Czech Republic; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
BRNO, Czech Republic; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
BRNO, Czech Republic; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
CESKE BUDEJOVICE, Czech Republic; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Ostrava Trebovice, Czech Republic; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
PRAHA 1, Czech Republic; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Praha 5, Czech Republic; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
PRAHA 5, Czech Republic; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Zlin, Czech Republic; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
Helsinki, Finland; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Kuopio, Finland; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Kuopio, Finland; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Oulu, Finland; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Oulu, Finland; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Oys, Finland; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Seinajoki, Finland; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Seinajoki, Finland; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Tampere, Finland; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Tampere, Finland; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Tampere, Finland; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Amiens, France; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy
Angers Cedex 1, France; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Angers Cedex 9, France; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Bethune, France; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Bethune, France; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Bron, France; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Dijon, France; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Dijon, France; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Lille, France; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Lille, France; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy
Lyon, France; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Marseille, France; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Montpellier Cedex, France; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Montpellier Cedex 5, France; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Nancy, France; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Paris, France; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy
Paris, France; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Paris, France; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Reims, France; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Reims, France; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy
Rennes, France; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Rennes, France; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Roanne, France; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
St Pierre Cedex, France; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Strasbourg, France; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Strasbourg, France; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Toulouse Cedex 04, France; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Berlin, Germany; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
Berlin, Germany; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Berlin, Germany; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Bernau, Germany; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
Bielefeld, Germany; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
Bonn, Germany; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Erlangen, Germany; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
Frankfurt, Germany; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Freiburg, Germany; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Freiburg, Germany; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Gφttingen, Germany; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
Heidelberg, Germany; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy
Jena, Germany; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
Kehl, Germany; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy
Kehl, Germany; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Kehl, Kork, Germany; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Kiel, Germany; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy
Liegau-Augustusbad, Germany; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Munchen, Germany; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Munchen, Germany; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Munchen, Germany; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Mόnchen, Germany; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
Mόnster, Germany; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy
Ulm, Germany; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Hong Kong, Hong Kong; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
Budapest, Hungary; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Debrecen, Hungary; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Pecs, Hungary; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Szeged, Hungary; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Zalaegerszeg, Hungary; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Bangalore, India; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
Bangalore, India; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Hyderabad, India; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
Hyderabad, India; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
Hyderabad, India; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Jaipur, India; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Kolkata, India; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Lucknow, India; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Mumbai, India; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
Mumbai, India; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
Mumbai, India; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
New Delhi, India; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
Pune, India; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Pune Maharashtra, India; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
Thiruvananthapuram, India; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Tirupati, India; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
Tel Aviv, Israel; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Bari, Italy; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
Bologna, Italy; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Bologna, Italy; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Milano, Italy; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Milano, Italy; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
Milano, Italy; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
Napoli, Italy; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Pavia, Italy; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
Roma, Italy; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
Siena, Italy; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
Gwangju, Korea; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
Seoul, Korea; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
Seoul, Korea; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
San Juan, PR, Mexico; Research Site
The purpose of this research program is to assess the effectiveness and safety of a study drug in patients with PGTC Seizures.
Breda, Netherlands; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Den Haag, Netherlands; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Heemstede, Netherlands; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Heeze, Netherlands; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Maastricht, Netherlands; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Zwolle, Netherlands; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Bergen, Norway; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
Fredrikstad, Norway; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
Oslo, Norway; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
Sandvika, Norway; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
Trondheim, Norway; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
Bialystok, Poland; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Gdansk, Poland; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Gdansk, Poland; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Katowice, Poland; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Katowice, Poland; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Kielce, Poland; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Lodz, Poland; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Lodz, Poland; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Lodz, Poland; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Lublin, Poland; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Lublin, Poland; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Szczecin, Poland; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Szczecin, Poland; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Warsaw, Poland; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Warszawa, Poland; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Warszawa, Poland; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Warszawa, Poland; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Warszawa, Poland; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
San Juan, Puerto Rico; Research Site
The purpose of this research program is to assess the effectiveness and safety of a study drug in patients with PGTC Seizures.
Seoul, Republic of Korea; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
Seoul, Republic of Korea; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
Kazan, Russian Federation; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
Moscow, Russian Federation; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
Moscow, Russian Federation; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
Moscow, Russian Federation; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
Moscow, Russian Federation; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
Moscow, Russian Federation; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
Moscow, Russian Federation; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
Samara, Russian Federation; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
St. Petersburg, Russian Federation; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
Yaroslavi, Russian Federation; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
Belgrade, Serbia and Montenegro; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Belgrade, Serbia and Montenegro; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Singapore, Singapore; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
Singapore, Singapore; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
Singapore, Singapore; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
George, South Africa; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
Johannesburg, South Africa; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
Tygeberg, South Africa; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
Alcorcon, Spain; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Barcelona, Spain; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Madrid, Spain; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Madrid, Spain; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Madrid, Spain; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Madrid, Spain; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
San Sebastian, Spain; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Vigo, Spain; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Goteborg, Sweden; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Gφteborg, Sweden; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
Stockholm, Sweden; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
Stockholm, Sweden; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
Umea, Sweden; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
Stockholm, Sweeden; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Biel, Switzerland; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Geneve, Switzerland; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
St Gallen, Switzerland; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Tschugg, Switzerland; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Zόrich, Switzerland; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
La Manouba, Tunisia; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Tunis, Tunisia; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Donetsk, Ukraine; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
Kharkov, Ukraine; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
Kyiv, Ukraine; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
Kyiv, Ukraine; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
Lviv, Ukraine; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
Odessa, Ukraine; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
Uzhgorod, Ukraine; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
